NatureWise Biotech & Medicals Corporation
4732.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$830.72M
Close$
Share Statistics
| Market cap | $830.72 Million |
|---|---|
| Enterprise Value | $741.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.89 |
| Beta | 0.57 |
| Outstanding Shares | 48,129,000 |
Return
| Return on Equity | -31.12% |
|---|---|
| Return on Assets | -26.82% |
| Return on Invested Capital | -37.94% |
Valuation & Multiples
| P/E Ratio | -6.23 |
|---|---|
| PEG | -4.35 |
| Price to Sales | 2.46 |
| Price to Book Ratio | 1.56 |
| Enterprise Value to Revenue | 2.09 |
| Enterprise Value to EBIT | -3.46 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NatureWise Biotech & Medicals Corporation
32 employees
CEO: Zhong Yang Huang NatureWise Biotech & Medicals Corporation is a Taiwanese entity primarily engaged in the creation of pharmaceutical solutions. Its product lineup features LipoCol Forte, a capsule designed to address elevated cholesterol and triglyceride...